Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2026-03-05 @ 6:40 PM
Study NCT ID:
NCT01419834
Status:
COMPLETED
Last Update Posted:
2023-08-04
First Post:
2011-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-08-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-02
Completion Date Type:
ACTUAL
First Submit Date:
2011-08-17
First Submit QC Date:
None
Study First Post Date:
2011-08-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-03
Last Update Post Date:
2023-08-04
Last Update Post Date Type:
ACTUAL